Spironolactone and Injectafer drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Spironolactone (spironolactone) and Injectafer (ferric carboxymaltose). Common drug interactions include insomnia among females and gout among males.

The phase IV clinical study analyzes what interactions people have when they take Spironolactone and Injectafer. It is created by eHealthMe based on reports of 41 people who take the same drugs from the FDA, and is updated regularly.

What is Spironolactone?

Spironolactone has active ingredients of spironolactone. It is often used in acne. eHealthMe is studying from 122,947 Spironolactone users. Check the latest studies of Spironolactone.

What is Injectafer?

Injectafer has active ingredients of ferric carboxymaltose. eHealthMe is studying from 3,270 Injectafer users. Check the latest studies of Injectafer.

On Jul, 26, 2026

41 people who take Spironolactone and Injectafer together, and have interactions are studied.

Spironolactone and Injectafer drug interactions.

What are the common drug interactions of Spironolactone and Injectafer, by gender? *:

female:

Insomnia (sleeplessness)
Anhedonia (inability to experience pleasure from activities usually found enjoyable)
Hypophosphataemia (electrolyte disturbance in which there is an abnormally low level of phosphate in the blood)
Pain
Abdominal pain
Pain in extremity
Impaired self-care
Spinal compression fracture (fracture due to spinal compression on bone)
Arthralgia (joint pain)
Constipation

male:

Gout (uric acid crystals building up in the body)
Chest pain

What are the common drug interactions of Spironolactone and Injectafer, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

Alopecia (absence of hair from areas of the body)
Blood phosphorus decreased
Dizziness

30-39:

Drug hypersensitivity
Headache (pain in head)

40-49:

White blood cell count decreased
Abdominal pain
Cough
Dizziness
Headache (pain in head)
Hospitalisation
Hot flush (sudden feelings of heat)
Sepsis (a severe blood infection that can lead to organ failure and death)
Vomiting

50-59:

Chest pain
Headache (pain in head)
Nausea (feeling of having an urge to vomit)
Vomiting

60+:

Oedema peripheral (superficial swelling)
Nausea (feeling of having an urge to vomit)
Abdominal pain
Anhedonia (inability to experience pleasure from activities usually found enjoyable)
Hypophosphataemia (electrolyte disturbance in which there is an abnormally low level of phosphate in the blood)
Impaired self-care
Pain
Spinal compression fracture (fracture due to spinal compression on bone)
Arthralgia (joint pain)
Constipation

What are the existing conditions these people have? *

Iron Deficiency Anaemia: 12 people, 29.27%
Ovarian Cancer (cancer of ovary): 9 people, 21.95%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 9 people, 21.95%
Pain In Extremity: 8 people, 19.51%
Cardiac Failure: 8 people, 19.51%
Cough: 7 people, 17.07%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 7 people, 17.07%
Pulmonary Hypertension (increase in blood pressure in the lung artery): 6 people, 14.63%
Nausea (feeling of having an urge to vomit): 6 people, 14.63%
Hypogammaglobulinaemia (an abnormally low concentration of gamma globulin in the blood and increased risk of infection): 6 people, 14.63%

* Approximation only. Some reports may have incomplete information.

Do you take Spironolactone and Injectafer?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously